⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a
very recent recall may be missing. Everything shown is accurate as of the last checked time on this page —
for anything time-critical, confirm with the official sources linked below.
FDAClass II · Drug · Recalled July 1, 2026
Corlanor (ivabradine) tablets recall — Amgen, Inc.
Hazard: Presence of Foreign Substance.
Class II: may cause temporary or medically reversible health consequences.
View the official FDA enforcement record (openFDA) ↗
- Official recall ID
- D-0615-2026
- Brand
- Amgen
- Classification
- Class II
- Units affected
- N/A
- Recall status
- Ongoing
- Initiated
- Voluntary: Firm initiated
Description
Corlanor (ivabradine) tablets, 7.5mg, 60-count bottles, Rx Only, Amgen Inc., Thousand Oaks, CA 92130 Made In Italy. NDC 55513-810-60
Affected products
Companies & origin
- Recalling firm location
- Thousand Oaks, CA, United States
- Firm address
- 1 Amgen Center Dr, N/A, 91320-1730
Identifying details (verbatim from the notice)
- Product codes / lots
- Lot #: 1138203, 1142065, Exp. Date 07/31/2026; 1145151, 1145152, 1145153, Exp. Date 2/28/2027; 1148908, 1148909, Exp. Date 05/31/2027; 1162845, 1162846, Exp. Date 11/30/2027; 1166471, 1166472, 1166473, Exp. Date 05/31/2028; 1170615, Exp. Date 08/31/2028
- Distribution
- Nationwide within the United States
- Firm notified the public via
- Letter
- FDA event ID
- 99077
- Recall initiated
- June 4, 2026
- FDA classified
- June 23, 2026
- FDA report date
- July 1, 2026
Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim;
the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.
Report a data error on this page